Tuesday, October 31, 2017

Drugmaker set to profit from an opioid it said was unsafe

WGNO-Oct 30, 2017
Endo contended that the new Opana ER and its hard coating deterred abuse, but this summer, the FDA disagreed. In June, the regulatory agency concluded that ...
Post a Comment